ID: ALA322959

Max Phase: Preclinical

Molecular Formula: C23H25N3O4Si

Molecular Weight: 435.56

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(N)ccc1c2[Si](C)(C)C

Standard InChI:  InChI=1S/C23H25N3O4Si/c1-5-23(29)16-9-18-19-14(10-26(18)21(27)15(16)11-30-22(23)28)20(31(2,3)4)13-7-6-12(24)8-17(13)25-19/h6-9,29H,5,10-11,24H2,1-4H3/t23-/m0/s1

Standard InChI Key:  DMTSPIIGVQTUPQ-QHCPKHFHSA-N

Associated Targets(Human)

HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
833K (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

DC3F (23 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 435.56Molecular Weight (Monoisotopic): 435.1614AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Josien H, Bom D, Curran DP, Zheng Y, Chou T.  (1997)  7-Silylcamptothecins (silatecans): A new family of camptothecin antitumor agents,  (24): [10.1016/S0960-894X(97)10181-0]

Source